Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Assoc Lab Anim Sci ; 62(2): 106-107, 2023 Mar 01.
Article in English | MEDLINE | ID: mdl-37061750
2.
Microbes Infect ; 25(3): 105045, 2023.
Article in English | MEDLINE | ID: mdl-36162750

ABSTRACT

Iron deficiency, the most common micronutrient deficiency in humans, is associated with long-term deficits in cognition and memory if left untreated. Infection with the gastric pathogen Helicobacter pylori has been linked to iron deficiency anemia (IDA). The H. pylori virulence factor cytotoxin-associated gene A (cagA) is proposed to be especially pertinent in iron deficiency. Male INS-GAS/FVB mice were infected with the CagA+ strain pre-murine Sydney strain 1 (PMSS1) for 12-13 or 27-29 weeks to investigate the role of chronic H. pylori infection in iron deficiency and neurological sequelae. Mice at both timepoints demonstrated significantly elevated gastric histopathology scores and inflammatory cytokines compared to sham-dosed controls. However, only mice at 27-29 weeks post infection had changes in hematological parameters, with significantly decreased erythrocyte count, hematocrit, serum hemoglobin, and increased serum total iron binding capacity. Gastric transcription of iron-regulatory genes Hamp and Bmp4 were significantly downregulated at both timepoints. In the brain, iron-dependent myelingergic and synaptic markers were significantly downregulated at 27-29 weeks. These results indicated that long-term infection of the CagA + PMSS1 strain of H. pylori in this study caused anemia, altered gastric iron homeostasis, and neurological changes similar to those reported in other rodent H. pylori CagA- strain infection models.


Subject(s)
Anemia, Iron-Deficiency , Helicobacter Infections , Helicobacter pylori , Iron Deficiencies , Humans , Male , Mice , Animals , Helicobacter pylori/genetics , Iron/metabolism , Anemia, Iron-Deficiency/complications , Anemia, Iron-Deficiency/pathology , Brain/pathology , Helicobacter Infections/pathology , Antigens, Bacterial/genetics , Antigens, Bacterial/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism
3.
Sci Adv ; 4(6): eaar8409, 2018 06.
Article in English | MEDLINE | ID: mdl-29963629

ABSTRACT

Dysfunctional endothelial cells contribute to the pathophysiology of many diseases, including vascular disease, stroke, hypertension, atherosclerosis, organ failure, diabetes, retinopathy, and cancer. Toward the goal of creating a new RNA-based therapy to correct aberrant endothelial cell gene expression in humans, efficient gene silencing in the endothelium of nonhuman primates was achieved by delivering small interfering RNA (siRNA) with 7C1, a low-molecular weight, ionizable polymer that forms nanoparticles. After a single intravenous administration of 1 mg of siRNA per kilogram of animal, 7C1 nanoparticles delivering Tie2 siRNA caused Tie2 mRNA levels to decrease by approximately 80% in the endothelium of the lung. Significant decreases in Tie2 mRNA were also found in the heart, retina, kidney, pancreas, and bone. Blood chemistry and liver function analysis before and after treatment all showed protein and enzyme concentrations within the normal reference ranges. Furthermore, after controlling for siRNA-specific effects, no significant increases in inflammatory cytokine concentrations were found in the serum. Similarly, no gross lesions or significant underlying pathologies were observed after histological examination of nonhuman primate tissues. This study is the first demonstration of endothelial gene silencing in multiple nonhuman primate organs using systemically administered siRNA nanoparticles and highlights the potential of this approach for the treatment of disease in humans.


Subject(s)
Endothelial Cells/metabolism , Gene Transfer Techniques , Ions , Nanoparticles , Polymers , RNA, Small Interfering/genetics , Animals , Biomarkers , Cytokines/biosynthesis , Gene Silencing , Humans , Inflammation Mediators/metabolism , Ions/chemistry , Molecular Structure , Nanoparticles/chemistry , Polymers/chemistry , Primates , RNA Interference , RNA, Messenger/genetics , RNA, Small Interfering/administration & dosage , RNA, Small Interfering/chemistry , Receptor, TIE-2/genetics
4.
Comp Med ; 68(4): 314-318, 2018 08 01.
Article in English | MEDLINE | ID: mdl-30012239

ABSTRACT

A 6-y-old, intact, pair-housed male common marmoset (Callithrix jacchus) presented with acute onset dyspnea and tachypnea immediately after sedation with alfaxalone; a history of gradual weight loss initiated the examination under sedation. Thoracic radiographs revealed significant right-lung consolidation, with a vesicular gas pattern in the right caudodorsal lung field, pleural effusion, and dorsal displacement of the heart. The marmoset was euthanized due to his unstable condition and poor prognosis. At necropsy, the cranial and middle lobes of the right lung were homogenously dark red-brown, enlarged, edematous, and twisted around the longitudinal axis at the hilus. The left lung lobes were pale pink and slightly edematous. In light of the clinical and gross necropsy findings, acute torsion of the right cranial and middle lung lobes was diagnosed. Predisposing conditions for lung lobe torsion include trauma, neoplasia, pulmonary disease, previous thoracic surgery, and diaphragmatic hernia, but none of these applied to this case. Initial therapy for lung lobe torsion is to stabilize the patient and treat for underlying conditions, with prompt surgical resection as the treatment of choice. To our knowledge, this report is the first description of lung lobe torsion in an experimentally unmanipulated New World NHP.


Subject(s)
Lung Diseases/veterinary , Lung/pathology , Monkey Diseases/diagnostic imaging , Animals , Callithrix , Lung Diseases/diagnostic imaging , Lung Diseases/pathology , Male , Monkey Diseases/pathology , Torsion Abnormality
SELECTION OF CITATIONS
SEARCH DETAIL
...